Table 5. Survival outcomes associated with mortality risk factor among cytomegalovirus (CMV)-infected patients.

	Univariate HR (95% CI)	p-value	Multivariate 1 HR (95% CI)	p-value	Multivariate 2 HR (95% CI)	p-value
Age	1.012 (0.981–1.044)	0.441	0.998 (0.957–1.041)	0.924	1.004 (0.964–1.045)	0.844
Female sex	1.026 (0.374–2.812)	0.961	1.082 (0.284–4.123)	0.908	1.037 (0.274–3.921)	0.958
Other infections	22.000 (2.750–175.971)	0.004	16.231 (1.846–142.681)	0.012	18.425 (2.109–161.006)	0.008
Log CMV PCR	1.479 (1.140–1.918)	0.003	1.415 (1.027–1.950)	0.034	1.409 (1.016–1.954)	0.040
Ganciclovir	0.543 (0.206–1.432)	0.217	0.864 (0.226–3.309)	0.864	0.815 (0.221–3.008)	0.759
Pulsed MPSL	0.948 (0.337–2.667)	0.920	1.331 (0.259–6.847)	0.732	1.548 (0.287–8.334)	0.611
Oral steroid	1.000 (0.999–1.001)	0.813	0.993 (0.982–1.004)	0.199	0.994 (0.983–1.005)	0.271
Log WBC count	1.384 (0.706–2.713)	0.345	1.342 (0.620–2.904)	0.455
Log Lymphocyte	1.153 (0.819–1.623)	0.414			1.319 (0.673–2.588)	0.420

Values are expressed as HR (95% CI). P-values were calculated using logistic regression models. CI, confidence interval; HR, hazard ratio; MPSL, methylprednisolone; WBC, white blood cell.